LV305
IMDZ-04-1702
Phase 3 mab terminated
Quick answer
LV305 for Synovial Sarcoma is a Phase 3 program (mab) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Synovial Sarcoma
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated